Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging therapeutic options for refractory gout.
Jatuworapruk K, Louthrenoo W. Jatuworapruk K, et al. Among authors: louthrenoo w. Nat Rev Rheumatol. 2024 Feb;20(2):73-74. doi: 10.1038/s41584-023-01066-5. Nat Rev Rheumatol. 2024. PMID: 38102493 No abstract available.
Effect of dominancy on severity in rheumatoid arthritis.
Boonsaner K, Louthrenoo W, Meyer S, Schumacher HR Jr. Boonsaner K, et al. Among authors: louthrenoo w. Br J Rheumatol. 1992 Feb;31(2):77-80. doi: 10.1093/rheumatology/31.2.77. Br J Rheumatol. 1992. PMID: 1737234
Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.
Golder V, Kandane-Rathnayake R, Hoi AY, Huq M, Louthrenoo W, An Y, Li ZG, Luo SF, Sockalingam S, Lau CS, Lee AL, Mok MY, Lateef A, Franklyn K, Morton S, Navarra ST, Zamora L, Wu YJ, Hamijoyo L, Chan M, O'Neill S, Goldblatt F, Morand EF, Nikpour M; Asia-Pacific Lupus Collaboration. Golder V, et al. Among authors: louthrenoo w. Arthritis Res Ther. 2016 Nov 9;18(1):260. doi: 10.1186/s13075-016-1163-2. Arthritis Res Ther. 2016. PMID: 27829463 Free PMC article.
Reply.
Louthrenoo W. Louthrenoo W. J Clin Rheumatol. 1998 Apr;4(2):106. doi: 10.1097/00124743-199804000-00017. J Clin Rheumatol. 1998. PMID: 19078265 No abstract available.
A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
Taylor WJ, Schumacher HR Jr, Baraf HS, Chapman P, Stamp L, Doherty M, McQueen F, Dalbeth N, Schlesinger N, Furst DE, Vazquez-Mellado J, Becker MA, Kavanaugh A, Louthrenoo W, Bardin T, Khanna D, Simon LS, Yamanaka H, Choi HK, Zeng X, Strand V, Grainger R, Clegg D, Singh JA, Diaz-Torne C, Boers M, Gow P, Barskova VG. Taylor WJ, et al. Among authors: louthrenoo w. Ann Rheum Dis. 2008 Jun;67(6):888-91. doi: 10.1136/ard.2007.079970. Epub 2007 Nov 29. Ann Rheum Dis. 2008. PMID: 18055475
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
163 results